Human bone marrow mesenchymal stem cells (MSCs) expanded in vitro exhibit not only a tendency to lose their proliferative potential, homing ability and telomere length but also genetic or epigenetic modifications, resulting in senescence. We compared differential methylation patterns of genes and miRNAs between early-passage [passage 5 (P5)] and late-passage (P15) cells and estimated the relationship between senescence and DNA methylation patterns. When we examined hypermethylated genes (methylation peak ≥ 2) at P5 or P15, 2,739 genes, including those related to fructose and mannose metabolism and calcium signaling pathways, and 2,587 genes, including those related to DNA replication, cell cycle and the PPAR signaling pathway, were hypermethylated at P5 and P15, respectively. There was common hypermethylation of 1,205 genes at both P5 and P15. In addition, genes that were hypermethylated at P5 (CPEB1, GMPPA, CDKN1A, TBX2, SMAD9 and MCM2) showed lower mRNA expression than did those hypermethylated at P15, whereas genes that were hypermethylated at P15 (MAML2, FEN1 and CDK4) showed lower mRNA expression than did those that were hypermethylated at P5, demonstrating that hypermethylation at DNA promoter regions inhibited gene expression and that hypomethylation increased gene expression. In the case of hypermethylation on miRNA, 27 miRNAs were hypermethylated at P5, whereas 44 miRNAs were hypermethylated at P15. These results show that hypermethylation increases at genes related to DNA replication, cell cycle and adipogenic differentiation due to long-term culture, which may in part affect MSC senescence.
Human bone marrow mesenchymal stem cells (MSCs) expanded in vitro exhibit not only a tendency to lose their proliferative potential, homing ability and telomere length but also genetic or epigenetic modifications, resulting in senescence. We compared differential methylation patterns of genes and miRNAs between early-passage [passage 5 (P5)] and late-passage (P15) cells and estimated the relationship between senescence and DNA methylation patterns. When we examined hypermethylated genes (methylation peak ≥ 2) at P5 or P15, 2,739 genes, including those related to fructose and mannose metabolism and calcium signaling pathways, and 2,587 genes, including those related to DNA replication, cell cycle and the PPAR signaling pathway, were hypermethylated at P5 and P15, respectively. There was common hypermethylation of 1,205 genes at both P5 and P15. In addition, genes that were hypermethylated at P5 (CPEB1, GMPPA, CDKN1A, TBX2, SMAD9 and MCM2) showed lower mRNA expression than did those hypermethylated at P15, whereas genes that were hypermethylated at P15 (MAML2, FEN1 and CDK4) showed lower mRNA expression than did those that were hypermethylated at P5, demonstrating that hypermethylation at DNA promoter regions inhibited gene expression and that hypomethylation increased gene expression. In the case of hypermethylation on miRNA, 27 miRNAs were hypermethylated at P5, whereas 44 miRNAs were hypermethylated at P15. These results show that hypermethylation increases at genes related to DNA replication, cell cycle and adipogenic differentiation due to long-term culture, which may in part affect MSC senescence.
Mesenchymal stem cells (MSCs) can be easily isolated, adhere proficiently to plastic and self-renew; they are considered to have great therapeutic potential. However, because they exist at low frequencies (0.01% to 0.001%) in bone marrow (BM) (Choi et al., 2010), it is necessary to expand MSCs ex vivo prior to clinical use. Previous studies have demonstrated that MSCs expanded in vitro exhibit a tendency to lose their proliferative potential, homing ability, capability to secrete cytokines, and, ultimately, undergo senescence (Bruder et al., 1997; Rombouts and Ploemacher, 2003; Choi et al., 2010). Meanwhile, some studies have reported that long-term MSC cultures displayed not only the shortening of telomeres and the absence of telomerase expression and activity (Baxter et al., 2004; Bernardo et al., 2007; Choi et al., 2010) but also genetic or epigenetic modifications, contributing to cellular senescence (Dahl et al., 2008; Bork et al., 2010).Expression of mammalian genes can be regulated by epigenetic processes, including DNA methylation, chromatin remodeling and the noncoding RNA-mediated mechanism (Bird, 2002). DNA methylation, which is the methylation of cytosines in CpG dinucleotides, favors genomic integrity and thus properly regulates gene expression (Antequera, 2003). Recently, some studies have analyzed methylation patterns of MSCs during long-term culture or differentiation and have suggested the possibility of epigenetic instability due to long-term culture as well as changes in gene methylation due to differentiation (Noer et al., 2006; Dahl et al., 2008; Bork et al., 2010). Bork et al. (2010) reported that highly significant differences in methylation patterns were observed at specific CpG sites, such as those near homeobox genes between early and late cultures. Meanwhile, using humanembryonic lung fibroblasts (HEFs), Zhang et al. (2008) compared DNA methylation globally with respect to replicative versus premature senescence induced by hydrogen peroxide. They reported that genome methylation levels decreased gradually, suggesting that changes in methylation might be partly responsible for cellular senescence.MicroRNAs (miRNAs), which are small (~22-nucleotide) noncoding RNA molecules that regulate the expression of genes related to the development, differentiation and proliferation of stem cells through complex regulatory networks (Hammond and Sharpless, 2008; Godlewski et al., 2010; Schaefer et al., 2010). Wagner et al. (2008) demonstrated that miRNAs, including has-mir-371, were up-regulated upon replicative senescence of MSCs, showing that senescence influences the expression of miRNAs. It has been reported that the expression of miRNAs may be regulated by the methylation of miRNA promoters (Liang et al., 2009). In addition, the methylation status of miRNA promoters may be indirectly associated with miRNA-directed post-transcriptional regulation of other factors, such as those in the methyltransferase family (Sinkkonen et al., 2008). Taken together, it is worth considering the relationship between methylation of miRNA promoters and expression of miRNAs upon replicative senescence of MSCs.In the present study, we measured the telomere shortening of human BM-derived MSCs as a result of long-term culture. We performed methylated DNA immunoprecipitation (MeDIP) assays and combined them with gene expression microarrays to compare differential methylation patterns of DNA and miRNA promoters between early (passage 5; P5) and late (passage 15; P15) passage cells. We also attempted to estimate the association between MSC senescence and DNA methylation patterns.
Results
Telomere shortening in long-term culture
Telomere shortening after each division cycle leads to gradual senescence. To evaluate telomere shortening, we measured the relative telomere length of MSCs at P5, P7, P9, P12 and P15 by the standard curve method (Figures 1A and 1B). T/S ratios, which indicate relative telomere length, of the cells continuously decreased from 2.85 at P5 to 1.6 at P15 and T/S ratios at P5 exhibited significant difference from these at P12 and P15 (Figure 1C). Applying a conversion factor (Cawthon, 2002) to convert T/S ratios into their corresponding mean TRF length at P5, P7, P9, P12 and P15 were 9.6, 9, 8.5, 8.2 and 7.2 kb, respectively; this results in shortening of the telomeres by 2.4 kb from P5 to P15.
Figure 1
Relative telomere length expressed as the T/S ratio. Using quantitative real-time PCR, relative telomere length of genomic DNAs from MSCs at various passages (P) (i.e., P5, P7, P9, P12 and P15) were calculated compared with human embryonic carcinoma NCCIT cells (reference). (A) The standard curve for telomere repeats (T). (B) The standard curve for the single-copy gene 36B4 (S). The standard curves for T and S were obtained from serial dilutions of genomic DNA (200 ng to 12.5 ng) from NCCIT cells (telomerase-positive cell line). (C) T/S ratios of MSCs obtained at P5, P7, P9, P12 and P15. T/S ratios indicate the relative telomere length and are represented as the mean ± SEM (n = 3) from three independent experiments. *Significantly different from P5 by a one-way ANOVA, followed by Tukey's HSD post hoc test (*P < 0.05).
Validation of MeDIP
To validate input and immunoaffinity-enriched DNA fragments (IEF) DNA from MSCs at P5 and P15, we amplified the GPR109A, SFRS5 and PEX13 promoters from the input and IEF using PCR as previously described (Weber et al., 2007). A band corresponding to the GPR109A promoter was detected in both the input and IEF samples at P5 and P15 (Figure 2). The band representing the SFRS5 promoter was much stronger in the input sample than that of IEF at P5 and P15. The patterns of these three promoters are in agreement with those reported by Weber et al. (2007), who demonstrated the successful enrichment of methylated DNA using MeDIP methodology. Therefore, the enrichment of methylated DNA in the MeDIP procedure was properly accomplished.
Figure 2
Validation of methyl-DNA immunoprecipitation (MeDIP). Genomic DNA from MSCs at P5 and P15 was sonicated and immunoprecipitated with 5-methylcytidine mAb. Validation of immunoaffinity-enriched DNA fragments (IEF) was performed using PCR. Input is the sonicated fragment.
Profiling of promoter DNA methylation and miRNA methylation
To compare differential promoter methylation patterns between P5 and P15 MSCs, we performed DNA methylation microarrays using NimbleGen human 2.1 M Deluxe Promoter Arrays. This array covers 10 kb of the promoter region for all known genes, including those near alternative transcription start sites. When we analyzed the methylation differences between P5 and P15, 3,338 genes showed more than two-fold higher methylation at P5 than P15, whereas 4,670 genes showed more than two-fold higher methylation at P15 than P5 (Figure 3A). Among 3,338 genes with higher methylation at P5, 2,867 (85.9%) were methylated at low CpG promoters (LCPs), and 471 (14.1%) were methylated at intermediate CpG promoters (ICPs); there were no genes at high CpG promoters (HCPs) (Figure 3B). In case of genes with higher methylation at P15, 4,026 (86.2%) were methylated at LCPs, and 644 (13.8%) were methylated at ICPs; again, there were no genes at HCPs.When we further analyzed genes exhibiting hypermethylated promoters (methylation peak ≥ 2) at P5 and P15, 2,739 genes were hypermethylated at P5, and 2,587 genes were hypermethylated at P15. The hypermethylation of 1,205 genes was shared between P5 and P15 (Figure 4). In the case of hypermethylated miRNAs (methylation peak ≥ 2), 27 miRNAs, including has-mir-136, has-mir-150, has-mir-200c and has-mir-618, were hypermethylated at P5, while 44 miRNAs, including has-let-7e, has-mir-27b, has-mir-411 and has-mir-195, were hypermethylated at P15 (Supplemental Data Figure S1). However, in the case of MSCs, most miRNAs hypermethylated at P5 and P15 have yet to be reported in epigenetic modification or gene expression.
Figure 4
Combination of hypermethylated genes and the summarized KEGG pathway. After sorting the genes hypermethylated (methylation peak ≥ 2) at P5 and P15 in MSCs, the data were classified using KEGG pathway analysis. Venn diagrams show hypermethylated genes at P5 and P15, including the overlap between P5 and P15.
Gene ontology and pathway analysis
To identify the biological processes (BP) of genes that showed methylation differences between P5 and P15, GO annotation (annotation category: GOTERM_BP_FAT) was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) functional annotation tool. Genes related to biological adhesion (GO:0022610) and cell adhesion (GO:0007155) were methylated at P5 more than twice as compared to P15 (Supplemental Data Table S1). Genes related to cell migration (GO:0016477), cell morphogenesis involved in differentiation (GO:0000904) and Wnt receptor signaling pathway through beta-catenin (GO:0060070) were methylated at P15 more than twice as compared to P5 (Supplemental Data Table S2). Promoters determined to be hypermethylated (methylation peak ≥ 2) at P5 and P15 were also classified with GO annotation (annotation category: GOTERM_BP_FAT). Of the 1,534 genes hypermethylated only at P5, more than 160 genes were commonly involved in phosphate metabolic process (GO:0006796) and cell adhesion (GO:0007155) (Figure 4) (Supplemental Data Table S3). Of the 1,382 genes hypermethylated only at P15, 175 genes were commonly involved in ion transport (GO:0006811), transmembrane transport (GO:0055085) and neuron differentiation (GO:0030182) (Figure 4) (Supplemental Data Table S4).To further examine potentially disrupted pathways due to hypermethylation, the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used. Genes related to fructose and mannose metabolism (GMPPA, KHK and so on), the calcium signaling pathway (CACNA1A, CALM1, etc.) and ubiquitin mediated proteolysis (UBA2, UBE3C, UBE2I, etc.) were mainly hypermethylated at P5, whereas genes related to DNA replication (POLE, FEN1, RFC2 and POLD4), cell cycle (CDC6, CDC27, CDK2 and so on), the MAPK signaling pathway (MAP3K6, MAP3K11, MAP4K2 and so on), astrocyte differentiation (GFAP) and target of the PPAR signaling pathway (ADIPOQ) were mainly hypermethylated at P15 (Figure 4). Comparing the hypermethylation of WNT subtypes between P5 and P15, most WNT subtypes (i.e., WNT4, WNT5A, WNT5B, WNT7B, WNT9B and WNT11) except WNT10A were specifically hypermethylated at P15, showing the possibility that the Wnt signaling pathway, which regulates cell fate, adhesion and migration (Nelson and Nusse, 2004), is down-regulated in late-passage MSCs, compared with early-passage MSCs.
Validation of differentially methylated genes
Differential methylation of promoters in CPEB1, TBX2 and SMAD9 genes was validated by semiquantitative methylation-specific PCR (MSP) after bisulfite modification. Based on the results obtained from DNA methylation microarrays, MSP primers were designed within sequences from peak start site to peak end site of methylation in gene promoter. Methylation density of CPEB1 and SMAD9 at P5 was greatly higher than unmethylation density of these genes, while unmethylation density of CPEB1 and SMAD9 at P15 increased compared to P5 (Figure 5A), showing the same pattern as DNA methylation microarray analysis (Figure 5B). On the other hand, methylation or unmethylation density of TBX2 at P5 was not changed at P15. This result is likely by examining a part sequence within promoter showing hypermethylated signal in DNA methylation microarray.
Figure 5
Correlation between DNA methylation and mRNA expression of MSCs. To evaluate DNA methyation and mRNA expression, MSCs harvested at P5 and P15 were used. (A) Methylation-specific PCR was performed using bisulfite-modified genomic DNA at P5 and P15. M, methylated product; U, unmethylated product. (B) DNA methylation was analyzed using NimbleGen human 2.1M Deluxe Promoter Array (NimbleGen). The value of each gene at P5 and P15 shows the ratio of immunoaffinity-enriched DNA fragments (IEF)/input, methylation intensity. The value of more than two means the hypermethylation of the gene. The value of low methylated or little methylated genes was not described. Input is the sonicated DNA fragment. (C) mRNA expression changes in MSCs at P5 and P15 were measured using RT-PCR.
Correlation of DNA methylation and gene expression
It has been generally known that DNA methylation represses gene expression. To analyze the correlation between DNA promoter methylation and gene expression, we observed mRNA expression of CPEB1, GMPPA, CDKN1A, TBX2, SMAD9, MCM2, MAML2, FEN1 and CDK4 genes in MSCs at P5 and P15. Genes (i.e., CPEB1, GMPPA, CDKN1A, TBX2, SMAD9 and MCM2) hypermethylated at P5 showed lower mRNA expression at P5 than at P15, whereas genes (i.e., MAML2, FEN1 and CDK4) hypermethylated at P15 showed lower mRNA expression at P15 than at P5 (Figures 5A and 5B). For these genes, hypermethylation at DNA promoter regions inhibited gene expression.
Discussion
The potential of proliferation and differentiation in adult stem cells obtained from various tissues is decreased during in vitro long-term culture, inducing their senescence. It has been reported that various mechanisms such as telomere shortening, histone modification, DNA methylation and miRNA expression affect the proliferation and differentiation of MSCs, resulting in cell senescence (Bonab et al., 2006; Noer et al., 2006; Wagner et al., 2008; Zhang et al., 2008; Bork et al., 2010). In the present study, we detected telomere shortening, which is a symptom of senescence, during long-term culture of MSCs as reported previously (Bonab et al., 2006; Choi et al., 2010).Recently, some studies have investigated DNA methylation of genes related to adipogenic differentiation and senescence in MSCs (Noer et al., 2006, 2007; Shibata et al., 2007). In a study by Noer et al. (2007), CpG methylation in the LEP promoter in MSCs from adipose tissue was changed due to senescence. Shibata et al. (2007) reported that promoter methylation of p16INK4A, which is a tumor suppressor gene, was higher for early-passage MSCs than for late-passage MSCs, showing that careful observation of DNA methylation should be considered during long-term culture of MSCs. A significant difference in methylation between early-passage and late-passage MSCs has also recently been reported (Bork et al., 2010). However, epigenetic regulation, such as change of DNA methylation in MSCs upon long-term culture, remained to be investigated. We therefore profiled DNA methylation to measure changes in the methylation patterns between early-passage and late-passage MSCs. Regarding greater than two-fold methylation differences for genes between early and late passages, more than 1,000 genes showed higher methylation at late passage than at early passage. In addition, genes exhibiting methylation differences between early and late passages were most located in LCPs, whereas no genes in HCPs were detected. Previous studies have reported that LCPs are not only associated with tissue-specific genes but also hypermethylated followed by down-regulation of genes, while genes containing HCPs are broadly expressed as well as hypomethylated (Elango and Yi, 2008; Rubinstein et al., 2010). The overall trend between methylation and CpG content in promoter of genes previously profiled by these research groups is consistent with our findings.When comparing hypermethylated genes at both early and late passages, methylation tended to be lower in late passage than in early passage, which is a result opposite from that regarding methylation differences between early and late passages. In a study by Zhang et al. (2008) that evaluated global DNA methylation in HEFs using an immunofluorescence assay, the global DNA methylation pattern decreased gradually upon prolonged culture. Nilsson et al. (2005) also reported that the overall level of DNA methylation in growth plate chondrocytes decreased during growth plate senescence. In contrast, Bork et al. (2010) observed that except for some genes such as homeobox genes, methylation patterns were maintained throughout long-term culture of BM-MSCs, showing different results than those in our present study. A possible reason for the discrepancy between Bork et al. and our observations may be the use of different detection and analysis methods. However, based on previous studies (Nilsson et al., 2005; Zhang et al., 2008) and the results presented here, the decrease in DNA methylation upon long-term culture may contribute to replicative senescence in cells having a finite proliferative capacity.In the GO analysis of genes with methylated promoters, genes related to cellular migration and morphogenesis or involved in differentiation were two times more methylated at late passage than at early passage. In addition, hypermethylated genes (methylation peak ≥ 2) were associated with transport and neuron differentiation and were hypermethylated at late passage. Considering that DNA methylation in part regulates gene silencing and that the differentiation potential of MSCs decreases at late passage (Suzuki and Bird, 2008; Choi et al., 2010), these results suggest that genes associated with differentiation may become methylated during long-term culture, leading to a decrease in differentiation potential.There were more gene promoters hypermethylated at early passage than at late passage, suggesting that early-passage MSCs show more stable gene silencing through promoter methylation than do late-passage MSCs. We also observed hypermethylation of BAD, BCL-2, CASP7 and CASP9, which belong to the apoptosis-related pathway, at early passage. Considering that three of these genes induce apoptosis, this result implies that silencing through hypermethylation may promote cell survival in early-passage MSCs but not in late-passage cells. Genes such as GADD45B and TP73, which belong to the p53 signaling pathway that is responsible for replicative senescence through growth arrest (Beausejour et al., 2003), were also hypermethylated at early passage, compared with late passage, suggesting that transcription of these genes is in part regulated by DNA methylation in the promoter. In addition, genes regulating cell cycle (CDK2, CDK4 and PCNA) and genes regulating DNA replication (POLE, POLD4 and RFC2) were hypermethylated at late passage, compared with early passage. Therefore, it is plausible that the reduction in DNA replication and cell proliferation that causes MSC senescence is related to promoter DNA methylation of these regulatory genes.Previous studies have shown that expression of genes related to differentiation as well as the adipogenic differentiation potential of MSCs decreases due to long-term culture (Digirolamo et al., 1999; Banfi et al., 2000; Noer et al., 2007). Noer et al. (2007) proposed the possibility of impairing up-regulation of LEP upon adipogenic stimulation in senescent MSCs due through changes in CpG methylation in the promoter, as previously mentioned. However, senescence did not induce changes in PPARG2, FABP4 and the LPL promoter CpG methylation. Interestingly in our study, adiponectin (ADIPOQ), which is a molecular marker for adipogenesis (Lara-Castro et al., 2007), was hypermethylated in late-passage cells, suggesting that its hypermethylation may in part be related to a decrease in adipogenic differentiation due to senescence. In the present study, we also showed that hypermethylated genes exhibited a decrease in mRNA expression, supporting this correlation between DNA methylation and gene expression.MSC senescence leads to an alteration in miRNA expression (Wagner et al., 2008). Ibanez-Ventoso et al. (2006) reported that miRNA expression decreased during aging in Caenorhabditis elegans. These studies imply that changes in miRNA expression are closely associated with cellular senescence or aging; they also shed light on the mechanisms, including genetic and epigenetic alterations that may affect miRNA expression. MiRNAs that were down-regulated in chronic lymphocytic leukemia compared with normal B-cells were methylated in their promoter regions, indicating that miRNA promoter methylation may be involved in transcriptional silencing of pri-miRNAs (Pallasch et al., 2009). In the present study, hypermethylation of has-miR-200c, which regulates BMI-1, a repressor of INK4a/ARF expression, and has-miR-210, which is induced as a cellular response to hypoxic stress (Crosby et al., 2009) in early-passage cells, decreased at late passage. In addition, has-miR-127, has-miR-130a, has-miR-136 and has-miR-150 were hypermethylated in early-passage cells, while has-miR-27b, has-miR-411 and has-miR-195 were hypermethylated at late-passage cells. Intriguingly, hypermethylated miRNAs increased at late passage as compared with early passage. Therefore, given an overall age-related decrease in miRNA expression (Liang et al., 2009) as well as the suppression of miRNA expression by methylation (Pallasch et al., 2009), it is possible that MSC senescence might induce the down-regulation of miRNAs through methylation.In conclusion, we profiled the genome-scale DNA and miRNA promoter methylation patterns of MSCs between early and late passages. We observed that genes exhibiting methylation differences between early and late passages were most located in LCPs. In addition, there were more gene promoters hypermethylated at early passage than at late passage. Our data show that long-term culture of MSCs causes major changes in the methylation pattern in DNA promoters. These findings may help our understanding of the mechanisms regulating senescence-associated epigenetic modifications.
Methods
MSC culture
The human BM-derived MSCs purchased from Lonza (lot 7F3674, Walkersville, ML) were cultured in Dulbecco's Modified Eagle's Medium-low glucose (DMEM-LG; Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA) at 37℃ in 5% CO2. After the MSCs reached 80% confluency, cells were subcultured using 0.25% trypsin/EDTA (Invitrogen, Carlsbad, CA). Informed consent was obtained from Poietics human mesenchymal stem cell systems (Lonza, Walkersville, ML).
Analysis of relative telomere length
Genomic DNA was purified from the experimental samples (MSCs at P5, P7, P9, P12 and P15) and the reference NCCIT cells (humanembryonic carcinoma cells; telomerase-positive cell line) using the Wizard® Genomic DNA Purification Kit (Promega, Madison, WI) as specified by the manufacturer. Relative telomere lengths were measured by quantitative real-time PCR amplification of telomere repeats (T) and the single-copy gene 36B4 (S) using the ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). The 36B4 gene was used to normalize variations in DNA concentration across samples. The primers and thermal cycling profiles were adopted from Cawthon (Cawthon, 2002). T and S standard curves (i.e., Ct vs. log quantity) were generalized using serial dilutions of DNA ranging from 200 to 12.5 ng from NCCIT as described previously (Guillot et al., 2007). Ct values in experimental samples were determined from semi-log amplification plots, and the standard curve was used to determine the quantity of telomere repeats. Note that this latter quantity is equivalent to the level of dilution of the arbitrary reference NCCIT needed to yield the same number of PCR cycles during the exponential phase. Relative telomere length was estimated as the Tquantity/Squantity (T/S) ratio, which is proportional to the mean terminal restriction fragment telomere (TRF) length (Cawthon, 2002). The telomere and 36B4 PCRs were run on separate plates, and the standard curve was included in each run to allow relative quantification between samples of 50 ng per sample. The concentration of reagents was 25 µl of SYBR® Premix Ex Taq™ II (Takara BIO, Shiga, Japan) and 1 µl of ROX, with the following final primer concentrations: Tel 1, 270 nM; Tel 2, 900 nM; 36B4u, 300 nM; and 36B4d, 500 nM. The thermal cycling conditions were initiated at 95℃ for 10 min; this step was followed by 40 cycles of 95℃ for 15 s and then 54℃ for 2 min for telomere PCR. This was followed by 40 cycles of 95℃ for 15 s and then 58℃ for 1 min for 36B4 PCR. The sequences of primers are listed in Supplemental Data Table S5.
MeDIP assay
The purification of genomic DNA from MSCs at P5 and P15 was performed using the Wizard® Genomic DNA Purification Kit (Promega, Madison, WI) as specified by the manufacturer. Before carrying out MeDIP, we sonicated genomic DNA to generate random fragments between 300 and 1,000 bp. Four µg of fragmented DNA was denatured for 10 min at 95℃ and immunoprecipitated with 10 µl of monoclonal antibody against 5-methylcytidine (Calbiochem, SanDiego, CA) in a final volume of 500 µl IP buffer (10 mM sodium phosphate, pH 7.0, 140 mM NaCl, 0.05% Triton X-100) for 2 h at 4℃. After adding 40 µl of Dynabeads® M-280 Sheep anti-Mouse IgG (Dynal Biotech, Oslo, Norway) to the mixture, it was incubated for 2 h at 4℃ and washed with 700 µl of IP buffer. Then the beads were collected, incubated with proteinase K for 3 h at 50℃, and then the methylated DNA was recovered by phenol-chloroform extraction followed by ethanol precipitation. To validate IEF, GPR109A, SFRS5 and PEX3 genes were amplified using PCR as previously described (Weber et al., 2007). The amplified products were evaluated by agarose gel electrophoresis. Primers used for MeDIP validation are listed in Supplemental Data Table S5.
Whole genome amplification of input and IEF
Whole genome amplification (WGA) of input and IP DNA from MSCs at P5 and P15 was performed using the GenomePlex WGA kit (Sigma, St. Louis, MO) according to the manufacturer's instructions. For OmniPlex library preparation, 10 µl of DNA solution (1 ng/µl of input or IEF) and 2 µl of 1× Library Stabilization Solution were mixed, incubated at 95℃ for 2 min, and then added to 1 µl of Library Preparation Enzyme. The mixture was performed in a PCR iCycler (Bio-Rad, Richmond, CA) at 16℃ for 20 min, 24℃ for 20 min, 37℃ for 20 min, and 75℃ for 5 min, and then it was held at 4℃. For WGA, the mixture was added to 7.5 µl of 10× Amplification Master Mix, 47.5 µl of Nuclease-free water and 5 µl of WGA DNA polymerase. Then the mixture was denatured at 95℃ for 3 min and then 40 cycles of 94℃ for 15 s and 65℃ for 5 min. The mixture was finally purified using the QIAquick PCR Purification Kit (Qiagen, Chatsworth, CA).
Hybridization of microarray
To examine the methylation pattern of genomic DNA at P5 and P15, two Human 2.1 M Deluxe Promoter Arrays (NimbleGen, Madison, WI) containing 28,266 CpG islands and 475 miRNA promoters were used. One µg of the amplified input and IEF DNA was separately labeled by Cy3-dCTP and Cy5-dCTP (GeneChem, Shanghai, China) using the BioPrime® Array CGH Genomic Labeling System (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Twenty-one µl (1 µg) of input (or IEF) and 20 µl of 2.5× random primer solution were mixed and denatured at 95℃ for 5 min. For labeling input and IEF DNA, 3 µl of Cy3- (orCy5-) dCTP, 5 µl of 10× dCTP nucleotide mixture and 1 µl of Klenow fragment (exo-) were added to the denatured mixture. The mixture was incubated at 37℃ for 2 h and then stopped with 5 µl of stop buffer. The labeled probes (Cy3-input and Cy5-IEF) were purified using the QIAquick PCR Purification Kit. The hybridization procedure was performed using the NimbleGen Hybrdization Kit according to the manufacturer's instructions. For hybridization, Cy3-input and Cy5-IEF were loaded on a Human 2.1M Deluxe Promoter Array (NimbleGen, Madison, WI), and then it was hybridized at 42℃ for 20 h using the MAUI 12-Bay Hybridization System (BioMicro Systems, Salt Lake City, UT). The hybridized array was washed with Wash I, II and III and then spin-dried.
Microarray analysis
We scanned the arrays with an Axon 4000B scanner and analyzed them using the NimbleScan 2.5 (NimbleGen, Madison, WI) software package and Microsoft Excel. Features with poor signal-to-noise ratios or saturated pixels were excluded from further analysis. We calculated the ratio between Cy3 and Cy5 signals for all high-quality features and normalized the ratio using NimbleScan 2.5 optimized settings. Methylated find-peak analysis based on the permutation-based algorithm was used to identify statistically significant peaks in the scaled log2-ratio data, which are likely to indicate methylation events. This analysis estimated the false discovery rate (FDR) for each peak (Benjamini and Hochberg, 1995) by repeatedly and randomly permuting the log-ratio data and searching for peaks. Strong peaks were characterized by consecutive probes with positive log-ratio values and generally low corresponding FDRs (P-value < 0.01). The resulting methylation values of promoter CpG sites were expressed by log2-transformation; therefore, methylation values of 1 indicate that the methylation of input was equal to the methylation of IP DNA. Methylation levels at P5 and P15 MSCs were calculated.The array data have been deposited in the Gene Expression Omnibus (GEO; http//www.ncbi.nlm.nih.gov/projects/geo/). The accession number for the data is GSE30018. The reviewer access link is http://www.ncbi.nlm.nih.gov/geo/info/linking.html.
Bioinformatics analyses
Human promoters could be classified into three categories to distinguish HCPs, LCPs and ICPs (Nelson and Nusse, 2004). We calculated CpG O/E in the promoter region, which is defined as 5 kp upstream to 1 kb downstream of the gene transcriptional start site as defined by NimbleGen. CpG O/E was calculated using the following formula: (CpG frequency)/(C frequency × G frequency). The three categories of promoters were defined: HCPs with CpG O/E above 0.75 and GC content (G and C frequency) above 55%; LCPs with a CpG O/E under 0.47; and remaining ICPs that were neither HCPs nor LCPs.Functions of differentially methylated genes between P5 and P15 MSCs were determined using v6.7. The physiological function of regulated genes was analyzed using the pathway analysis and visualization tool (http://www.asgbioinformatics.wur.nl/) (Te Pas et al., 2007).Pathway analysis of genes in methylation peaks showing P-value scores more than two-fold meaning P-values (≤ 0.01) at P5 and P15 was performed using KEGG pathway database (http://www.genome.jp/kegg/pathway.html).
MSP
Sodium bisulfite modification of genomic DNA from MSCs at P5 and P15 was performed using MethylEasy™ DNA Bisulphite Modification Kit (Human Genetic Signatures, Randwick, Australia) as specified by the manufacturer. Twenty µl of genomic DNA (2,000 ng/µl) was bisulfite converted. This step leads to the deamination of non-methylated cytosines to uracils whereas methylated cytosines are not modified by bisulfite. After bisulfite modification, genomic DNA concentration was measured using e-spect ES-2 spectrophotometer (Malcom). Methylation changes of the CpGs of three gene promoters (SMAD9, CPEB1 and FEN1) were validated using MSP. The MSP primers were designed using MethPrimer software (available on the World Wide Web at http://www.urogene.org/methprimer/) and are listed in Supplemental Data Table S5. Three µl of bisulfite-modified DNA, 10 pmol of each MSP primer set, and 15 µl of EF-Taq Premix II (SolGent, Daejeon, Korea) were mixed with water to a final volume of 30 µl. The mixture was amplified by hot-start PCR (iCycler, Bio-Rad, Richmond, CA) as follows: 32 cycles of 1 min of denaturation at 94℃, 1 min of annealing at 56oC, and 1 min of elongation at 72℃. Ten µl of the PCR product was loaded onto a 10% polyacrylamide gel. The DNA was
visualized by staining with EtBr.
RT-PCR
Total RNA extracted from MSCs at P5 and P15 was reverse-transcribed with SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA). The synthesized cDNA was mixed with 2× EF-Taq Premix II (SolGent, Daejeon, Korea), and gene-specific primers were synthesized by Genotech (Daejeon, Korea). The sequences of the primers (CPEB1, GMPPA, CDKN1A, TBX2, SMAD9, MCM2, MAML2, FEN1, CDK4 and β-actin) are listed in Supplemental Data Table S5. PCR was performed using Swift™ MaxPro Thermal Cycler (Esco, Oak Ridge, NJ). The amplification conditions consisted of an initial melt at 94℃ for 4 min, followed by 22 to 35 cycles of denaturation at 94℃ for 1 min, annealing at 60℃ for 1 min, extension at 72℃ for 1 min and final extension at 72℃ for 10 min. The amplified products were evaluated by polyacrylamide gel electrophoresis.
Statistical analysis
The relative telomere length was expressed as the mean ± standard error of measurement (SEM) from three independent experiments. Statistical analysis was performed using SPSS 13.0 (SPSS Inc., Chicago, IL). The data were tested using a one-way ANOVA followed by post hoc testing with Tukey's honestly significant difference (HSD) test, and P-values < 0.05 were considered significant.
Authors: Ola Nilsson; Robert D Mitchum; Lenneke Schrier; Sandra P Ferns; Kevin M Barnes; James F Troendle; Jeffrey Baron Journal: J Endocrinol Date: 2005-07 Impact factor: 4.286
Authors: Christian Philipp Pallasch; Michaela Patz; Yoon Jung Park; Susanne Hagist; Daniela Eggle; Rainer Claus; Svenja Debey-Pascher; Alexandra Schulz; Lukas P Frenzel; Julia Claasen; Nadine Kutsch; Günter Krause; Christine Mayr; Andreas Rosenwald; Christoph Plass; Joachim L Schultze; Michael Hallek; Clemens-Martin Wendtner Journal: Blood Date: 2009-08-19 Impact factor: 22.113
Authors: Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono Journal: Stem Cells Date: 2004 Impact factor: 6.277
Authors: Marinus F W Te Pas; Ina Hulsegge; Albart Coster; Marco H Pool; Henri H Heuven; Luc L G Janss Journal: BMC Dev Biol Date: 2007-06-13 Impact factor: 1.978
Authors: Barbara Bournet; Marion Gayral; Jérôme Torrisani; Janick Selves; Pierre Cordelier; Louis Buscail Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742
Authors: John K Wiencke; Rondi Butler; George Hsuang; Melissa Eliot; Stephanie Kim; Manuel A Sepulveda; Derick Siegel; E Andres Houseman; Karl T Kelsey Journal: Epigenetics Date: 2016-03-11 Impact factor: 4.528
Authors: Agustín F Fernández; Gustavo F Bayón; Rocío G Urdinguio; Estela G Toraño; María G García; Antonella Carella; Sandra Petrus-Reurer; Cecilia Ferrero; Pablo Martinez-Camblor; Isabel Cubillo; Javier García-Castro; Jesús Delgado-Calle; Flor M Pérez-Campo; José A Riancho; Clara Bueno; Pablo Menéndez; Anouk Mentink; Katia Mareschi; Fabian Claire; Corrado Fagnani; Emanuela Medda; Virgilia Toccaceli; Sonia Brescianini; Sebastián Moran; Manel Esteller; Alexandra Stolzing; Jan de Boer; Lorenza Nisticò; Maria A Stazi; Mario F Fraga Journal: Genome Res Date: 2014-09-30 Impact factor: 9.043
Authors: Rachel K Okolicsanyi; Emily T Camilleri; Lotta E Oikari; Chieh Yu; Simon M Cool; Andre J van Wijnen; Lyn R Griffiths; Larisa M Haupt Journal: PLoS One Date: 2015-09-10 Impact factor: 3.240
Authors: Daniel Gaston; Samantha Hansford; Carla Oliveira; Mathew Nightingale; Hugo Pinheiro; Christine Macgillivray; Pardeep Kaurah; Andrea L Rideout; Patricia Steele; Gabriela Soares; Weei-Yuarn Huang; Scott Whitehouse; Sarah Blowers; Marissa A LeBlanc; Haiyan Jiang; Wenda Greer; Mark E Samuels; Andrew Orr; Conrad V Fernandez; Jacek Majewski; Mark Ludman; Sarah Dyack; Lynette S Penney; Christopher R McMaster; David Huntsman; Karen Bedard Journal: PLoS Genet Date: 2014-10-23 Impact factor: 5.917
Authors: Hazel A Cruickshanks; Tony McBryan; David M Nelson; Nathan D Vanderkraats; Parisha P Shah; John van Tuyn; Taranjit Singh Rai; Claire Brock; Greg Donahue; Donncha S Dunican; Mark E Drotar; Richard R Meehan; John R Edwards; Shelley L Berger; Peter D Adams Journal: Nat Cell Biol Date: 2013-11-24 Impact factor: 28.824